Post by PARI

Big news! 🚀 We’re thrilled to announce that PARI has received 510(k) clearance for the eRapid® with eTrack® Controller – paving the way for the launch of our first connected nebulizer system in the U.S. The eTrack Controller features smart connectivity to inhalation therapy: ✔ Stores inhalation data and syncs via Bluetooth® and Wi-Fi® ✔ Capable of transferring inhalation data to a patient support app as well as to HCPs and clinical teams ✔ Can improve therapy adherence and supports data-based decisions eTrack, part of PARI’s eFlow® Technology platform, has been used as investigational device in clinical trials for many years. This milestone now sets an important precedent for future submissions, potentially simplifying regulatory processes for our pharma partners adopting eTrack in clinical trials or commercial settings. 👉 Learn more about our connected solutions and partner with us to shape the future of inhalation therapy: https://lnkd.in/dxB3e2wd   #inhalation #respiratory #drugdelivery #pharmapartnering #ConnectedHealth #DigitalHealth #MedicalDevices